|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Multidrug resistance 1 gene in inflammatory bowel disease: A meta-analysis显示文摘MDR1 基因是为煽动性的肠疾病(IBD ) 并且也许的致病的吸引人的候选人基因对治疗的反应,与在功能、基因的层次的证据。它的产品, P-glycoprotein (P-gp ) 作为因此影响许多药的布置和反应的 transmembrane 流出泵工作,一些(即 glucocorticoids ) 对 IBD 中央治疗。另外, P-gp 高度在许多上皮的表面被表示,包括的胃肠道(官方补给) 与在减少的一个通常认为的角色吸收内长或外毒素,并且也许主人细菌相互作用。MDR1 基因的许多基因变化被描述了,在为不同 P-gp 表示的一些例子证据,也,药新陈代谢被提供了。然而,数据经常由于采用的基因异质和不同方法论正在冲突。也许,在官方补给的道的 P-gp 的生理的重要性的证据的最大的片来自对老鼠建模的 mdr1 大美人的描述,它在特定的没有病原体的环境开发自发的大肠炎。学习调查到 IBD 的基因多型性和倾向也显示出冲突结果的 MDR1,由于在复杂疾病的已知的困难,特别当建议基因贡献是弱的时。在这研究,我们承担了在 IBD 与二 SNP 多型性(C3435T 和 G2677T/A ) 获得的可得到的调查结果的元分析;3435T 等位基因和 3435TT 遗传型的一个重要协会与 UC 被发现了(或 = 1.17, P = 0.003 并且或 = 1.36, P = 0.017,分别地) 。在对比,有 CD 和 G2677T/A 多型性的协会都不能被表明。 | V Annese MR Valvano O Palmieri A Latiano F Bossa A Andriulli | 2006 | World Journal of Gastroenterology2006，12，23： | 14 |
| 2 | Role of CARD15,DLG5 and OCTN genes polymorphisms in children with inflammatory bowel diseases显示文摘AIM: To investigate the contribution of variants of CARD15, OCTN1/2 and DLG5 genes in disease predispo- sition and phenotypes in a large Italian cohort of pediatric patients with inflammatory bowel diseases (IBD). METHODS: Two hundred patients with Crohn’s disease (CD), 186 ulcerative colitis (UC) patients, 434 par- ents (217 trios), and 347 healthy controls (HC) were studied. Polymorphisms of the three major variants of CARD15, 1672C/T and -207G/C SNPs for OCTN genes, IGR2096a_1 and IGR2198a_1 SNPs for the IBD5 locus, and 113G/A variant of the DLG5 gene were evaluated. Potential correlations with clinical sub-phenotypes were investigated. RESULTS: Polymorphisms of CARD15 were significantly associated with CD, and at least one variant was found in 38% of patients (15% in HC, OR = 2.7, P < 0.001). Homozygosis for both OCTN1/2 variants was more com- mon in CD patients (1672TT 24%, -207CC 29%) than in HC (16% and 21%, respectively; P = 0.03), with an in- creased frequency of the TC haplotype (44.8% vs 38.3% in HC, P = 0.04). No association with the DLG5 variant was found. CD carriers of OCTN1/2 and DLG5 variants more frequently had penetrating disease (P = 0.04 and P = 0.01), while carriers of CARD15 more frequently had ileal localization (P = 0.03). No gene-gene interaction was found. In UC patients, the TC haplotype was morefrequent (45.4%, P = 0.03), but no genotype/phenotype correlation was observed. CONCLUSION: Polymorphisms of CARD15 and OCTN genes, but not DLG5 are associated with pediatric on- set of CD. Polymorphisms of CARD15, OCTN, and DLG5 genes exert a weak influence on CD phenotype. | S Cucchiara A Latiano O Palmieri AM Staiano R D'Incà G Guariso G Vieni V Rutigliano O Borrelli MR Valvano V Annese | 2007 | World Journal of Gastroenterology2007，13，8： | 9 |
| 3 | Usefulness of ω-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: A double-blind, randomized, placebo-controlled study显示文摘AIM: To assess the value of long-chain ω-3 fatty acids (FAs) supplementation in addition to amino-salicylic-acid (5-ASA) in pediatric patients with Crohn's disease (CD).METHODS: Thirty-eight patients (20 males and 18females, mean age 10.13 years, range 5-16 years)with CD in remission were randomized into two groups and treated for 12 mo. Group Ⅰ (18 patients) received 5-ASA (50 mg/kg/d)+ω-3 FAs as triglycerides in gastroresistant capsules, 3 g/d (eicosapentanoic acid, EPA, 400mg/g, docosahexaenoic acid, DHA, 200 mg/g). Group Ⅱ (20 patients) received 5-ASA (50 mg/kg/d)+olive oil placebo capsules. Patients were evaluated for fatty acid incorporation in red blood cell membranes by gas chromatography at baseline 6 and 12 mo after the treatment.RESUJLTS: The number of patients who relapsed at 1year was significantly lower in group Ⅰ than in group Ⅱ(P<0.001). Patients in group Ⅰ had a significant increase in the incorporation of EPA and DHA (P<0.001) and a decrease in the presence of arachidonic acids.CONCLUSION: Enteric-coated ω-3 FAs in addition to treatment with 5-ASA are effective in maintaining remission of pediatric CD. | C Romano S Cucchiara A Barabino V Annese C Sferlazzas SIGENP Italian Study Group of Pediatric Inflammatory Bowel Diseases | 2005 | World Journal of Gastroenterology2005，11，45： | 4 |
| 4 | A multicentre randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia显示文摘 | V Annese G Bassotti G Coccia | 2000 | Gut2000，46，： | 2 |
| 5 | Gender-strati- fled analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian eohorts显示文摘 | Browning BL Annese V Barclay ML | 2008 | J Med Genet2008，45，1： | 1 |
| 6 | Guidelines for treat- ment of acute pancreatitis显示文摘 | Andriulli A Perri F Annese V | 1999 | Gut1999，44，4： | 1 |
| 7 | Guidelines for treatment of acute pancreatitis显示文摘 | ANDRULLI A PERRI F ANNESE V | 1999 | Gut1999，44，4： | 1 |
| 8 | Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis:a GISC study显示文摘 | Annese V Andreoli A Andriulli A | 2001 | Am J Gastroenterol2001，96，8： | 1 |
| 9 | Guidelines for treatment of acute pancreatitis 显示文摘 | Andrulli A Perri F Annese V | 1999 | Gut1999，44，4： | 1 |
| 10 | Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus显示文摘 | ANNESE V LOMBARDI G FRUSCIANTE V | 1997 | Aliment Pharmacol Ther1997，11，3： | 1 |
| 11 | Guidelines for treatment of acute pancreatitis显示文摘 | Andrulli A Perri F Annese V | 1999 | Gut1999，44，： | 1 |
| 12 | Guidelines for treatment of acute pancreatitis显示文摘 | Andrulli A Perri F Annese V | 1999 | Gut1999，44，： | 1 |
| 13 | Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial显示文摘 | VEMIA P ANNESE V BRESCI G | 2003 | Eur J Clin Invest2003，33，3： | 1 |
| 14 | Guidelines for treatoot of acute pancreatisis显示文摘 | Andrulli A Perd F Annese V | 1999 | Guh1999，44，： | 1 |
| 15 | Guidelines for treatment of acute pancreatitis显示文摘 | Andrulli A Perii F Annese V | 1999 | Gut1999，44，4： | 1 |
| 16 | Guidelines for treatment of acute pancreatitis显示文摘 | Andrulli A Perri F Annese V | 1999 | Gut1999，21，9： | 1 |
| 17 | European evidence based consensus for endoscopy in inflammatory bowel disease显示文摘 | Annese V Daperno M Rutter MD | 2013 | J Crohns Colitis2013，7，12： | 1 |
| 18 | Erythromycin accelerates gastric emptying by inducing antral contractions and improved gastroduodenal coordination显示文摘 | Annese V Janssens J Vantrappen G | 1992 | Gastroenterology1992，102，： | 1 |
| 19 | Topical butyrate improves efficacy of 52ASA in refractory distal ulcerative colitis: results of a multicentre trial显示文摘 | Vemia P Annese V Bresci G | 2003 | Eur J Clin Invest2003，33，3： | 1 |
| 20 | Long-term follow-up of achalasic patients treated with botulinum toxin显示文摘 | Onofrio V D'Onfrio V annese P | 2002 | Pig Liver Dis2002，31，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员